CollPlant Issues Shareholder Letter

CollPlant, a company focused on regenerative and aesthetic medicine, has released a letter to its shareholders. The communication likely addresses the company's recent developments, strategic direction, and financial performance. Given the recent termination of its partnership with AbbVie and workforce reductions, this letter is anticipated to provide crucial updates and context for investors. Shareholders will be looking for clarity on the company's path forward and its plans to navigate the challenges ahead.